Wed, 28 Jul 2010 00:00:00 GMT 4th Latin American Conference on Lung Cancer (LALCA 2010) dates: 28 - 30 July 2010 location: Buenos Aires, Argentina organizer: International Association for the Study of Lung Cancer (IASLC) The 4th Latin American Conference on Lung Cancer (www.lalca2010.org) will be an exciting time for lung cancer professionals from Latin America around the world to share the most up-to-date information regarding the science and advances in the treatment of lung cancer. International and national speakers will participate int he Scientific Program and their presentations will provide a platform to discuss the latest developments in basic science and clinical treatment.
Tue, 31 Aug 2010 00:00:00 GMT International Course in Nutritional Epidemiology (2nd Ed) dates: 31 August-10 September 2010, followed by the WCRF International Conference (12 -13 September 2010) location: London, UK organizer: Imperial College London Please see http://www.imperial.ac.uk/medicine/nutritionalepidemiology for more information
Thu, 02 Sep 2010 00:00:00 GMT Linz-Congress 2010 dates: 02 - 04 September 2010 location: University of Linz, Austria organizer: ESTIV / EUSAAT / zet I. Toxicological effects<br/>II. Novel approaches/methodologies<br/>III. Cross-cutting issues<br/>IV. Regulatory application of alternative methods<br/>V. Free communications
Sat, 04 Sep 2010 00:00:00 GMT The EMBO Meeting 2010 - advancing the life sciences dates: 4-7 September 2010 location: Barcelona, Spain organizer: EMBO Fast-paced conceptual and technological advances are profoundly changing the landscape of molecular biology research in terms of the depth and nature of biological insights gained. The programme for The EMBO Meeting 2010 highlights the dynamism of the field and features many leading researchers as speakers.
Tue, 07 Sep 2010 00:00:00 GMT 4th ESO - CNIO Familial Cancer Conference dates: 7-8 June 2010 location: Madrid organizer: European School of Oncology (ESO) - Spanish Nationa Cancer Research Centre (CNIO) Organisers: J. Benitez (CNIO) and H. Vasen (Leiden University Medical Centre)
Wed, 08 Sep 2010 00:00:00 GMT World Molecular Imaging Congress 2010 dates: 8-11 September 2010 location: Kyoto, Japan organizer: SMI, AMI, FASMI, ESMI, ISMRM, RSNA, SNM It is with great pleasure that we invite you to participate in the upcoming World Molecular Imaging Congress 2010 (WMIC) on September 8-11, 2010 in Kyoto, Japan.
Sun, 12 Sep 2010 00:00:00 GMT ESTRO 29 dates: 12 - 16 September 2010 location: Barcelona, Spain organizer: ESTRO ESTRO 29 will offer an outstanding scientific programme that will provide the most relevant and cutting edge science and education in radiation oncology, radiation biology, radiation physics and technology.
Wed, 15 Sep 2010 00:00:00 GMT Long term survival after R0 resection in locally advanced gastric cancer dates: 15 – 17 September 2010 location: Bordeaux, France organizer: ESSO Background: Long term survival after R0 resection in locally advanced gastric cancer (LAGC) remains poor, suggesting that a true curative treatment is seldom performed. Preoperative treatment protocols have been proven to be effective in LAGC by large-scale randomized trials theoretically through an increased control on distant and loco-regional recurrencies. Aim of this study is the evaluation of the effects induced by preoperative chemotherapy and its survival impact on a series of locally advanced gastric carcinomas.
Tue, 21 Sep 2010 00:00:00 GMT Targeted Cancer Therapies Congress 2010 dates: 21-23 September 2010 location: Zurich organizer: Terrapinn The Targeted Cancer Therapy World Congress 2010 is an executive-level, interactive conference experience tackling the biggest issues facing the oncology industry today. Visit the website: www.terrapinn.com/2010/tct
Wed, 22 Sep 2010 00:00:00 GMT Canadian Association of Radiation Oncology Annual Scientific Meeting dates: 22-25 September 2010 location: Hyatt Regency Hotel, Vancouver, BC organizer: Mary Hooey The CARO 2010 Annual Scientific Meeting has been developed to provide an opportunity for participants to interact with colleagues and experts in the field of physics. This meeting will allow participants to:<br/>•Describe the new trends and discovery in collaborative in Radiation Oncology and Physics.<br/>Set the base of common goal and future collaboration in education and research in Radiation Oncology and Physics.<br/>•Better understand and articulate the role of the physicist and the radiation oncologist to promote high standard of care in radiation therapy.<br/>•Understand the impact of new technology on the workload and treatment access to radiation therapy program.<br/>•Understand the importance of collaboration between medical physics and clinician for the education of resident in physics and radiation therapy.
Wed, 22 Sep 2010 00:00:00 GMT 10th International Conference on Cancer-Induced Bone Disease dates: 22 - 25 September 2010 location: Sheffield, UK organizer: Cancer and Bone Society - www.cancerandbonesociety.org Despite exciting recent advances there is still much to discover about the effects of cancers and cancer treatments on bone and mineral homeostasis.
Sat, 25 Sep 2010 00:00:00 GMT Expert Practice in Hematology dates: 25th of september location: Hotel Sofitel Lisboa, Lisbon Portugal organizer: prIME Oncology On behalf of Aristoteles Giagounidis, MD, PhD, meeting chairman, we are pleased to invite you to the Expert Practice in Hematology meeting in Lisbon, Portugal, on 25 September 2010.<br/><br/>During this case-based meeting, leaders in the field will discuss, in an interactive format, clinical issues encountered daily by practicing physicians. <br/><br/>Travel grants may be available for qualifying physicians interested in attending this educational activity. Please contact prIME Oncology regarding the availability of travel grant assistance via email at info@prIMEoncology.org
Mon, 27 Sep 2010 00:00:00 GMT PIVAC - 10 Progress in Vaccination against Cancer - supported by EACR dates: 27 - 30 September 2010 location: Cambridge, UK organizer: EACR The PIVAC annual conferences remain true to ideals of the first in the series, which also took place in Cambridge, in 2001. They are public but limited in size to maximally 90 participants, are residential, and provide much scope for close interactions among attendees in addition to offering an exciting program of presentations. This year, the emphasis will be on adjuvants, peptide and DNA vaccines, T cell monitoring and T cell adoptive immunotherapy.<br/>A meeting report will be published in "Cancer Immunology Immunotherapy" along with "Focussed Research Reviews" loosely based on the presentations of selected speakers.<br/>We look forward to welcoming you to Cambridge later this year.<br/>
Tue, 28 Sep 2010 00:00:00 GMT 16th International Charles Heidelberger Symposium on Cancer Research dates: 26-28 September 2010 location: Coimbra, Portugal organizer: ACIMAGO The Charles Heidelberger Symposia are broad cancer research meetings organized annually or biennially to honor the late Charles Heidelberger, former president of the American Association for Cancer Research and an extraordinary scientist in the fields of carcinogenesis and cancer chemotherapy (he patented 5FU, 5-fluorouracil). The 16th edition of the Symposia will bring together scientists from around the world to present their achievements and discuss the most recent advances in cancer, from basic research to clinical applications.
Wed, 29 Sep 2010 00:00:00 GMT Optimizing Early Phase Oncology Studies to Accelerate Proof of Concept dates: 29 - 30 September 2010 location: Brussels, Belgium organizer: NextLevel Pharma When running early clinical trials for experimental new drugs across a range of therapeutic areas, demonstrating "proof of concept" is a critical milestone of the development process. It is at this stage where exploratory studies become confirmatory studies and there is a basis for studying the efficacy in a larger population. From a business perspective, showing proof of concept is also an essential bargaining chip when negotiating licensing agreements.<br/><br/>Due to the prevalence, diversity and complexity of cancer, oncology clinical trials have evolved along a different path than trials for other therapeutic areas. The toxicity ratings, patient recruitment and stratification, and the ethical aspects all have considerations specific to oncology trials. Despite these differences, oncology drugs face the same industry-wide problem of high attrition rates and low levels of efficiency in clinical trials. The potential therapeutic and commercial value of these drugs need to be determined at an early stage so resources can be allocated more efficiently.
Thu, 30 Sep 2010 00:00:00 GMT 5th Annual Meeting German Society of Stem Cell Research (GSZ) dates: 30 September - 02 October 2010 location: Lübeck, Germany organizer: Conventus Congressmanagement & Marketing Welcome Note<br/><br/>Dear Colleagues and Friends,<br/> <br/>it is our great pleasure, on behalf of the German Society for Stem Cell Research<br/>(GSZ), to extend you a warm invitation to attend the 5th Annual Conference of the GSZ in Lübeck. The conference will take place at the Campus of the University of Lübeck from 30 September – 2 October, 2010, and will bring together scientists from academia, industry and clinical research to stimulate and promote the exchange of ideas and information about stem cell biology. The meeting will cover a range of current topics of stem cell research including somatic and embryonic stem cells as well as induced pluripotent cells, tissue regeneration, ethical aspects and the biology of tumor stem cells. <br/> <br/>In particular, we encourage young scientists and students to take part in this meeting since we have arranged large space for poster presentations and short talks. There will be ample opportunities to discuss state of the art approaches and consult with the experts in both, informal discussions and formal panel sessions. Students will pay a very much reduced registration fee, and a discount will also be available to GSZ members. <br/> <br/>The Conference will take place in the Auditorium Maximum on the University<br/>Campus. There will be many opportunities for the participants to join discussion<br/>groups and to share interesting findings in stem cell biology studies. To stress the importance of the attendance of young investigators Poster Prices will be awarded. <br/> <br/>See you in Lübeck!<br/><br/><br/>Organizing Committee Lübeck<br/>Jürgen Rohwedel
Sun, 03 Oct 2010 00:00:00 GMT Stem Cells and Cancer - 6th International Heinrich F.C. Behr Symposium dates: 03 - 05 October 2010 location: Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany organizer: DKFZ, NCI and Leopoldina In this symposium, the molecular and cellular basis of normal and malignant stem cells will be discussed and first approaches to target and eliminate cancer stem cells will be presented.